Gefitinib (Chemogef (250 mg)) is a chemotherapy agent, prescribed for non-small cell lung cancer.It blocks the action of a certain substance that may be needed for cancer cell multiplication.

Safety. The IDEAL trials showed that gefitinib was generally well tolerated at both 250 and 500 mg/day, and that the most common drug-related adverse events were mild diarrhoea and skin reactions.

the original daily dose of 250 mg should be reinstituted, since there are no consensus guidelines for dose reduction and gefitinib is not supplied in lower-strength tablets. 25 In the United ...

The cost for a pack of 250-mg tablets (30 tablets per pack) is £2,167.71 (excluding VAT, BNF edition 59). The manufacturer has agreed with the Department of Health a patient access scheme in which ...

Gefitinib is given orally at a recommended dosage of 250 mg once daily. The cost for a 30‑tablet pack of 250‑mg tablets is £2,167.71 (excluding VAT; BNF, accessed online September 2015). Costs may ...

strong>Astrazeneca plc, of London, said the FDA approved Iressa (gefitinib) tablets, 250 mg once daily, for the first-line treatment of patients with metastatic non-small-cell lung cancer (NSCLC) ...

Gefitinib (Geftiget 250 mg) is a chemotherapy agent, prescribed for non-small cell lung cancer.It blocks the action of a certain substance that may be needed for cancer cell multiplication.